2021 DORIS definition of remission in SLE: final recommendations from an international task force.
cam.issuedOnline | 2021-11-24 | |
dc.contributor.author | van Vollenhoven, Ronald F | |
dc.contributor.author | Bertsias, George | |
dc.contributor.author | Doria, Andrea | |
dc.contributor.author | Isenberg, David | |
dc.contributor.author | Morand, Eric | |
dc.contributor.author | Petri, Michelle A | |
dc.contributor.author | Pons-Estel, Bernardo A | |
dc.contributor.author | Rahman, Anisur | |
dc.contributor.author | Ugarte-Gil, Manuel Francisco | |
dc.contributor.author | Voskuyl, Alexandre | |
dc.contributor.author | Arnaud, Laurent | |
dc.contributor.author | Bruce, Ian N | |
dc.contributor.author | Cervera, Ricard | |
dc.contributor.author | Costedoat-Chalumeau, Nathalie | |
dc.contributor.author | Gordon, Caroline | |
dc.contributor.author | Houssiau, Frédéric A | |
dc.contributor.author | Mosca, Marta | |
dc.contributor.author | Schneider, Matthias | |
dc.contributor.author | Ward, Michael M | |
dc.contributor.author | Alarcon, Graciela | |
dc.contributor.author | Aringer, Martin | |
dc.contributor.author | Askenase, Anka | |
dc.contributor.author | Bae, Sang-Cheol | |
dc.contributor.author | Bootsma, Hendrika | |
dc.contributor.author | Boumpas, Dimitrios T | |
dc.contributor.author | Brunner, Hermine | |
dc.contributor.author | Clarke, Ann Elaine | |
dc.contributor.author | Coney, Cindy | |
dc.contributor.author | Czirják, László | |
dc.contributor.author | Dörner, Thomas | |
dc.contributor.author | Faria, Raquel | |
dc.contributor.author | Fischer, Rebecca | |
dc.contributor.author | Fritsch-Stork, Ruth | |
dc.contributor.author | Inanc, Murat | |
dc.contributor.author | Jacobsen, Søren | |
dc.contributor.author | Jayne, David | |
dc.contributor.author | Kuhn, Annegret | |
dc.contributor.author | van Leeuw, Bernadette | |
dc.contributor.author | Limper, Maarten | |
dc.contributor.author | Mariette, Xavier | |
dc.contributor.author | Navarra, Sandra | |
dc.contributor.author | Nikpour, Mandana | |
dc.contributor.author | Olesinska, Marzena Helena | |
dc.contributor.author | Pons-Estel, Guillermo | |
dc.contributor.author | Romero-Diaz, Juanita | |
dc.contributor.author | Rubio, Blanca | |
dc.contributor.author | Schoenfeld, Yehuda | |
dc.contributor.author | Bonfá, Eloisa | |
dc.contributor.author | Smolen, Josef | |
dc.contributor.author | Teng, YK Onno | |
dc.contributor.author | Tincani, Angela | |
dc.contributor.author | Tsang-A-Sjoe, Michel | |
dc.contributor.author | Vasconcelos, Carlos | |
dc.contributor.author | Voss, Anne | |
dc.contributor.author | Werth, Victoria P | |
dc.contributor.author | Zakharhova, Elena | |
dc.contributor.author | Aranow, Cynthia | |
dc.contributor.orcid | van Vollenhoven, Ronald F [0000-0001-6438-8663] | |
dc.contributor.orcid | Doria, Andrea [0000-0003-0548-4983] | |
dc.contributor.orcid | Morand, Eric [0000-0002-9507-3338] | |
dc.contributor.orcid | Petri, Michelle A [0000-0003-1441-5373] | |
dc.contributor.orcid | Pons-Estel, Bernardo A [0000-0003-2518-0266] | |
dc.contributor.orcid | Ugarte-Gil, Manuel Francisco [0000-0003-1728-1999] | |
dc.contributor.orcid | Arnaud, Laurent [0000-0002-8077-8394] | |
dc.contributor.orcid | Bruce, Ian N [0000-0003-3047-500X] | |
dc.contributor.orcid | Houssiau, Frédéric A [0000-0003-1451-083X] | |
dc.contributor.orcid | Aringer, Martin [0000-0003-4471-8375] | |
dc.contributor.orcid | Bae, Sang-Cheol [0000-0003-4658-1093] | |
dc.contributor.orcid | Boumpas, Dimitrios T [0000-0002-9812-4671] | |
dc.contributor.orcid | Brunner, Hermine [0000-0001-9478-2987] | |
dc.contributor.orcid | Dörner, Thomas [0000-0002-6478-7725] | |
dc.contributor.orcid | Jacobsen, Søren [0000-0002-5654-4993] | |
dc.contributor.orcid | Teng, YK Onno [0000-0001-9920-2195] | |
dc.contributor.orcid | Tsang-A-Sjoe, Michel [0000-0002-4982-3505] | |
dc.contributor.orcid | Werth, Victoria P [0000-0003-3030-5369] | |
dc.contributor.orcid | Aranow, Cynthia [0000-0001-9299-0053] | |
dc.date.accessioned | 2022-02-14T14:00:34Z | |
dc.date.available | 2022-02-14T14:00:34Z | |
dc.date.issued | 2021-11 | |
dc.date.submitted | 2021-07-12 | |
dc.date.updated | 2022-02-14T14:00:33Z | |
dc.description.abstract | OBJECTIVE: To achieve consensus on a definition of remission in SLE (DORIS). BACKGROUND: Remission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force consisting of patient representatives and medical specialists published a framework for such a definition, without reaching a final recommendation. METHODS: Several systematic literature reviews were performed and specific research questions examined in suitably chosen data sets. The findings were discussed, reformulated as recommendations and voted on. RESULTS: Based on data from the literature and several SLE-specific data sets, a set of recommendations was endorsed. Ultimately, the DORIS Task Force recommended a single definition of remission in SLE, based on clinical systemic lupus erythematosus disease activitiy index (SLEDAI)=0, Evaluator's Global Assessment <0.5 (0-3), prednisolone 5 mg/day or less, and stable antimalarials, immunosuppressives, and biologics. CONCLUSION: The 2021 DORIS definition of remission in SLE is recommended for use in clinical care, education, and research including clinical trials and observational studies. | |
dc.identifier.doi | 10.17863/CAM.81413 | |
dc.identifier.eissn | 2053-8790 | |
dc.identifier.issn | 2053-8790 | |
dc.identifier.other | lupus-2021-000538 | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/334001 | |
dc.language | en | |
dc.language.iso | eng | |
dc.publisher | BMJ | |
dc.publisher.url | http://dx.doi.org/10.1136/lupus-2021-000538 | |
dc.subject | healthcare | |
dc.subject | lupus erythematosus | |
dc.subject | outcome assessment | |
dc.subject | systemic | |
dc.subject | therapeutics | |
dc.subject | Humans | |
dc.subject | Immunosuppressive Agents | |
dc.subject | Lupus Erythematosus, Systemic | |
dc.subject | Prednisolone | |
dc.subject | Remission Induction | |
dc.subject | Severity of Illness Index | |
dc.title | 2021 DORIS definition of remission in SLE: final recommendations from an international task force. | |
dc.type | Article | |
dcterms.dateAccepted | 2021-11-04 | |
prism.issueIdentifier | 1 | |
prism.publicationName | Lupus Sci Med | |
prism.volume | 8 | |
pubs.funder-project-id | UCB Pharma (n/a) | |
pubs.funder-project-id | GlaxoSmithKline (n/a) | |
rioxxterms.freetoread.startdate | 2021-11-23 | |
rioxxterms.licenseref.startdate | 2021-11-23 | |
rioxxterms.licenseref.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1136/lupus-2021-000538 |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- lupus-2021-000538.pdf
- Size:
- 832.54 KB
- Format:
- Adobe Portable Document Format
- Description:
- Published version
- Licence
- http://creativecommons.org/licenses/by-nc/4.0/
No Thumbnail Available
- Name:
- lupus-2021-000538.xml
- Size:
- 84.38 KB
- Format:
- Extensible Markup Language
- Description:
- Bibliographic metadata
- Licence
- http://creativecommons.org/licenses/by-nc/4.0/